Kariv Tomer 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Kariv Tomer
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-01-30+2,859→ 2,859 totalExercise: $4.00Exp: 2033-01-30→ Common Stock (2,859 underlying)
Footnotes (2)
- [F1]The stock option vests as to 50% of the underlying shares on the first anniversary of January 30, 2023, and the remaining 50% of the underlying shares will vest in twelve (12) equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
- [F2]The Reporting Person will assign the economic interests of this grant to the Pontifax funds, where he serves as a director of the General Partner.